Lee 2002.
Study characteristics | ||
Methods | RCT | |
Participants | Inclusion criteria:
Exclusion criteria: |
|
Interventions | Intervention 1: 5HT3 antagonist (Comparison 1)
Intervention 2: 5HT3 antagonist (Comparison 1)
Intervention 3: 5HT3 antagonist (Comparison 1)
Comparator: placebo
|
|
Outcomes | VAS pain scores, emetic episodes, emesis scores, side effects | |
Notes | Setting: Samsung Cheil Hospital, Seoul, South Korea. Dates: not reported. Funding source: not reported. Declaration of interest: not reported. Full paper in English. There were no data for this review |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "randomised according to computerised list" |
Allocation concealment (selection bias) | Unclear risk | Unrelated anaesthetist prepared syringes |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | As above |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Quote: "post operative emetic scores were recorded by anesthesiologist blinded to which antiemetic each patient had received" |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Not clear if any data incomplete/missing |
Selective reporting (reporting bias) | Unclear risk | outcomes appear to be consistent with methods, but we did not assess the trial protocol |
Other bias | Unclear risk | Nil apparent |